Triazole-resistant candidaemia following posaconazole exposure

International Journal of Antimicrobial Agents

Volumn 33, Issue 5, 2009, Pages 494-495

  Weiler, Stefan ^a   Lass Flörl, Cornelia ^a   Auberger, Jutta ^a   Bellmann Weiler, Rosa ^a   Stein, Markus ^a   Joannidis, Michael ^a   Bellmann, Romuald ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; TRIAZOLE DERIVATIVE; VANCOMYCIN; VORICONAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; CANDIDA GLABRATA; CANDIDEMIA; CASE REPORT; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION PREVENTION; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PRIORITY JOURNAL;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGEMIA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; TRIAZOLES; YOUNG ADULT;

EID: 62949160280     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.12.001     Document Type: Letter

References (9)

1. Torres H.A., Hachem R.Y., Chemaly R.F., Kontoyiannis D.P., and Raad I.I. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5 (2005) 775-785
2. Ullmann A.J., Lipton J.H., Vesole D.H., Chandrasekar P., Langston A., Tarantolo S.R., et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356 (2007) 335-347
3. Ullmann A.J., Lipton J.H., Vesole D.H., Chandrasekar P., Langston A., Tarantolo S.R., et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 357 (2007) 428 (Erratum)
4. Cornely O.A., Maertens J., Winston D.J., Perfect J., Ullmann A.J., Walsh T.J., et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356 (2007) 348-359
5. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 2nd ed. Document M27-A2. Wayne, PA: CLSI; 2002.
6. Wingard J.R., Merz W.G., Rinaldi M.G., Johnson T.R., Karp J.E., and Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325 (1991) 1274-1277
7. Marty F.M., Cosimi L.A., and Baden L.R. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 350 (2004) 950-952
8. Verweij P.E., Mellado E., and Melchers W.J. Multiple-triazole-resistant aspergillosis. N Engl J Med 356 (2007) 1481-1483
9. van Leer-Buter C., Takes R.P., Hebeda K.M., Melchers W.J., and Verweij P.E. Aspergillosis-and a misleading sensitivity result. Lancet 370 (2007) 102